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Abstract 
Context: Dillenia (Dilleniaceae) is a genus of about 100 species of flowering plants in 
tropical and subtropical trees of Southern Asia, Australasia, and the Indian Ocean Islands. 
Until now, only eight Dillenia species have been reported to be used traditionally in different 
countries for various medical purposes. Out of eight species, D. pentagyna (Roxb), D. indica 
(Linn.) and D. suffruticosa (Griffith Ex. Hook. F. & Thomsom Martelli) have been reported 
to be used to treat cancerous growth. Objective: The present review explored and provided 
information on the therapeutic potential of Dillenia species. Methods: Comprehensive and 
relevant literature on the therapeutic potential of Dillenia species was gathered through 
electronic databases including Google Scholar, Scopus, PubMed, and books, without limiting 
the dates of publication. Results and conclusion: The review demonstrated that only a few 
Dillenia species have been proven scientifically for their therapeutic potential in pre-clinical 
studies, including D. pentagyna, D. indica, D. papuana (Martelli), D. meliosmifolia (Hook. F. 
Ex. Thomsom) and D. suffruticosa (Griffith Ex Hook. F. & Thomson). A few species of 
Dillenia have undergone isolation and characterization of compounds with lupeol and 
betulinic acids having tremendous pharmacological potential. Dillenia species warrant further 
studies on their therapeutic potential, which may eventually lead to the development of new 
drug candidates for treatment of various diseases. 
 
Keyword: Active constituent(s); Dilleniaceae; Ethnomedicinal; Pharmacological 
  
 
